Cannabis and epilepsy: An ancient treatment returns to the fore

Epilepsy and Behavior

Volumn 70, Issue , 2017, Pages 292-297

  Russo, Ethan B ^a  

^a PHYTECS   (United States)

Author keywords

Cannabidiol; Cannabis; Epilepsy; Marijuana; Seizure disorder; Tetrahydrocannabinol

Indexed keywords

CANNABIDIOL; CANNABIS; TETRAHYDROCANNABINOL; CANNABINOID; DRONABINOL; MEDICAL CANNABIS; NABIXIMOLS;

ANTIQUITY; ARAB; ASIA; EPILEPSY; EUROPE; HISTORY OF MEDICINE; HUMAN; INDIA; ISLAM; MIDDLE AGES; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); REVIEW; TRADITIONAL HEALER; WESTERN MEDICINE; DRUG COMBINATION; HISTORY; NORTH AMERICA; SEIZURE;

CANNABIDIOL; CANNABINOIDS; CANNABIS; DRONABINOL; DRUG COMBINATIONS; EPILEPSY; EUROPE; HISTORY, ANCIENT; HUMANS; INDIA; MEDICAL MARIJUANA; NORTH AMERICA; SEIZURES;

EID: 85008391974     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2016.09.040     Document Type: Review

References (69)

1. Driver, G.R., Reginald Campbell Thompson: 1876–1941. Proc Br Acad 30 (1941), 446–485.
2. Thompson, R.C., The Assyrian herbal. 1924, Luzac and Co., London.
3. Thompson, R.C., A dictionary of Assyrian botany. 1949, British Academy, London.
4. Thompson, R.C., A dictionary of Assyrian chemistry and geology. 1936, Clarendon Press, Oxford.
5. Farber, W., Drogen im Alten Mesopotamien- Sumerer und Akkader. Volger, G., (eds.) Rausch und Realitat: Drogen im Kulturvergleich, 1981, Rautenstrauch-Joest-Museum, Cologne, 270–291.
6. Russo, E.B., History of cannabis and its preparations in saga, science and sobriquet. Chem Biodivers 4 (2007), 2624–2648.
7. Thompson, R.C., Assyrian medical texts from the originals in the British Museum. 1923, Oxford University Press, London.
8. Oppenheim, A.L., Reiner, E., Biggs, R.D., The Assyrian dictionary. 1968, Oriental Institute of the University of Chicago, Chicago.
9. Thompson, R.C., Assyrian prescriptions for treating bruises or swellings. Am J Semit Lang Lit 47 (1930), 1–25.
10. Thompson, R.C., Assyrian prescriptions for the “hand of a ghost”. J R Asiat Soc G B Irel 29 (1929), 801–823.
11. Thompson, R.C., Assyrain prescriptions for diseases of the ears. J. R. Asiat. Soc. G. B. Irel., 1–23, 1931.
12. Wilson, J.V., Reynolds, E.H., Texts and documents. Translation and analysis of a cuneiform text forming part of a Babylonian treatise on epilepsy. Med Hist 34 (1990), 185–198.
13. Russo, E.B., Cannabis in India: ancient lore and modern medicine. Mechoulam, R., (eds.) Cannabinoids as therapeutics, 2005, Birkhäuser Verlag, Basel, Switzerland, 1–22.
14. Dash, V.B., Fundamentals of Ayurvedic medicine. Revised and enlarged. Ed. 1999, Sri Satguru Publications, Delhi.
15. Lozano, I., Solaz del espíritu en el hachís y el vino y otros textos árabes sobre drogas. 1998, Universidad de Granada, Granada, Spain.
16. Rosenthal, F., The herb; hashish versus medieval Muslim society. 1971, Leiden, Brill.
17. Mechoulam, R., The pharmacohistory of Cannabis sativa. Mechoulam, R., (eds.) Cannabinoids as therapeutic agents, 1986, CRC Press, Boca Raton, FL, 1–19.
18. Lozano, I., The therapeutic use of Cannabis sativa L. in Arabic medicine. J Cannabis Ther 1 (2001), 63–70.
19. Lozano, I., Estudios y documentos sobre la historia del cáñamo y del hachís en el islam medieval. In: Departamento de Estudios Semíticos. 1993, Universidad de Granada, Granada, Spain.
20. Matthioli, P.A., Ne I sei libri della materia medicinale di Pedacio Dioscoride Anazarbeo. 1557, Eramo, Venice, Italy.
21. Parkinson, J., Bonham, T., L'Obel, M., Theatrum botanicum: the theater of plants; or, an herball of a large extent … distributed into sundry classes or tribes, for the more easie knowledge of the many herbes of one nature and property, with the chiefe notes of Dr. Lobel, Dr. Bonham, and others inserted therein. 1640, Tho. Cotes, London.
22. Russo, E.B., History of cannabis as medicine: nineteenth century Irish physicians and correlations of their observations to modern research. Chanda, S., Lata, H., Elsohly, M., (eds.) Cannabis sativa L.: botany and biotechnology, 2017 [in press].
23. O'Shaughnessy, W.B., On the preparations of the Indian hemp, or gunjah (Cannabis indica); their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Trans Med Phys Soc Bengal 71–102 (1838–1840), 421–461.
24. Nadkarni, K.M., Nadkarni, A.K., Indian materia medica. With Ayurvedic, Unani-Tibbi, Siddha, allopathic, homeopathic, naturopathic & home remedies, appendices & indexes, 3rd ed, 1976, Popular Prakashan, Bombay.
25. Ley, W., On the efficacy of Indian hemp in some convulsive disorders. Provincial Med Surg J 4 (1842), 407–409.
26. Christison, R., A dispensatory or commentary on the pharmacopoeias of Great Britain and the United States. 1848, Lea and Blanchard, Philadelphia.
27. McMeens, R.R., Cannabis indica in convulsions. West Lancet, 1856, 327–331.
28. McMeens RR. Report of the Ohio state medical committee on Cannabis indica. In. White Sulphur Springs, OH: Ohio State Medical Society; Vol. 1860. p. 75–100.
29. Willis, I.P., Cannabis indica. Boston Med Surg J 61 (1859), 173–178.
30. Reynolds, J.R., On some of the therapeutical uses of Indian hemp. Arch Med 2 (1868), 154–160.
31. Reynolds, J.R., Therapeutical uses and toxic effects of Cannabis indica. Lancet 1 (1890), 637–638.
32. Perez-Reyes, M., Wingfield, M., Letter: cannabidiol and electroencephalographic epileptic activity. JAMA, 230, 1974, 1635.
33. Russo, E.B., Mathre, M.L., Byrne, A., Velin, R., Bach, P.J., Sanchez-Ramos, J., et al. Chronic cannabis use in the compassionate investigational new drug program: an examination of benefits and adverse effects of legal clinical cannabis. J. Cannabis Ther. 2 (2002), 3–57.
34. Rubin, V.D., Comitas, L., Ganja in Jamaica: a medical anthropological study of chronic marihuana use. 1975, Mouton, The Hague.
35. Stefanis, C.N., Dornbush, R.L., Fink, M., Hashish: studies of long-term use. 1977, Raven Press, New York.
36. Cohen, S., The 94-day cannabis study. Ann N Y Acad Sci 282 (1976), 211–220.
37. Carter, W.E., Cannabis in Costa Rica: a study of chronic marihuana use. 1980, Institute for the Study of Human Issues, Philadelphia.
38. Consroe, P.F., Wood, G.C., Buchsbaum, H., Anticonvulsant nature of marihuana smoking. JAMA 234 (1975), 306–307.
39. Karler, R., Turkanis, S.A., The antiepileptic potential of the cannabinoids. Cohen, S., Stillman, R.C., (eds.) The therapeutic potential of marihuana, 1976, Plenum Medical Book Company, New York, 383–397.
40. Consroe, P., Martin, P., Eisenstein, D., Anticonvulsant drug antagonism of delta9tetrahydrocannabinol-induced seizures in rabbits. Res Commun Chem Pathol Pharmacol 16 (1977), 1–13.
41. Karler, R., Turkanis, S.A., Cannabis and epilepsy. Adv Biosci, 1978 [22–23: 619–41].
42. Karler, R., Turkanis, S.A., Cannabis and epilepsy. Nahas, G.G., Paton, W.D.M., (eds.) Marihuana biological effects: Analysis, metabolism, cellular responses, reproduction and brain, 1979, Pergamon Press, Oxford, UK, 619–641.
43. Cunha, J.M., Carlini, E.A., Pereira, A.E., Ramos, O.L., Pimentel, C., Gagliardi, R., et al. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 21 (1980), 175–185.
44. Carlini, E.A., Cunha, J.M., Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol 21 (1981), 417S–427S.
45. Ames, F.R., Cridland, S., Anticonvulsant effect of cannabidiol. S Afr Med J, 69, 1986, 14.
46. Consroe, P., Snider, S.R., Therapeutic potential of cannabinoids in neurological disorders. Mechoulam, R., (eds.) Cannabinoids as therapeutic agents, 1986, CRC Press, Boca Raton, FL, 21–49.
47. Trembly, B., Sheman, M., Double-blind clinical study of cannabidiol as a secondary anticonvulsant. Marijuana '90 international conference on cannabis and cannabinoids. Kolympari, Crete, Greece, 1990.
48. Grinspoon, L., Bakalar, J.B., Marihuana, the forbidden medicine. Rev. and exp. ed. 1997, Yale University Press, New Haven.
49. Petro, D.J., Seizure disorders. Mathre, M.L., (eds.) Cannabis in medical practice: a legal, historical and pharmacological overview of the therapeutic use of marijuana, 1997, McFarland and Co., Jefferson, NC, 125–128.
50. Gieringer, D., Medical use of cannabis: experience in California. Grotenhermen, F., Russo, E., (eds.) Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential, 2001, Haworth Press, Binghamton, NY, 153–170.
51. Corral, V.L., Differential effects of medical marijuana based on strain and route of administration: a three-year observational study. J. Cannabis Ther. 1 (2001), 43–59.
52. Grotenhermen, F., Schnelle, M., Survey on the medical use of cannabis and THC in Germany. J. Cannabis Ther. 3 (2003), 17–40.
53. British Medical Association, Therapeutic uses of cannabis. 1997, Harwood Academic Publishers, Amsterdam.
54. Joy, J.E., Watson, S.J., Benson, J.A. Jr., Marijuana and medicine: assessing the science base. In. 1999, Institute of Medicine, Washington, DC.
55. Hollister, L.E., Marijuana (cannabis) as medicine. J. Cannabis Ther. 1 (2001), 5–27.
56. Wallace, M.J., Martin, B.R., DeLorenzo, R.J., Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 452 (2002), 295–301.
57. Wallace, M.J., Blair, R.E., Falenski, K.W., Martin, B.R., DeLorenzo, R.J., The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 307 (2003), 129–137.
58. Gieringer, D., Medical cannabis potency testing project. Bull Multidiscip Assoc Psychedelic Stud 9 (1999), 20–22.
59. Ware, M.A., Adams, H., Guy, G.W., The medicinal use of cannabis in the UK: results of a nationwide survey. Int J Clin Pract 59 (2005), 291–295.
60. Pelliccia, A., Grassi, G., Romano, A., Crocchiolo, P., Treatment with CBD in oily solution of drug-resistant paediatric epilepsies. In: International Association of Cannabinoid Medicines. 2005, Leiden, Netherlands, International Association of Cannabinoid Medicines.
61. Lorenz, R., On the application of cannabis in paediatrics and epileptology. Neuroendocrinol Lett, 25, 2004 [In Press].
62. Gottschling, S., Cannbinoide bei Kindern. Gute Erfahrungen bei Schmerzen, Spastik und in der Onkologie Angewandte Schmerztherapie und Palliativmedizin, 2011, 55–57.
63. Jones, N.A., Hill, A.J., Smith, I., Bevan, S.A., Williams, C.M., Whalley, B.J., et al. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. J Pharmacol Exp Ther 332 (2010), 569–577.
64. Maa, E., Figi, P., The case for medical marijuana in epilepsy. Epilepsia 55 (2014), 783–786.
65. Porter, B.E., Jacobson, C., Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav 29 (2013), 574–577.
66. Devinsky, O., Cilio, M.R., Cross, H., Fernandez-Ruiz, J., French, J., Hill, C., et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 55 (2014), 791–802.
67. Devinsky, O., Marsh, E., Friedman, D., Thiele, E., Laux, L., Sullivan, J., et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol 15 (2016), 270–278.
68. Press, C.A., Knupp, K.G., Chapman, K.E., Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy Behav 45 (2015), 49–52.
69. Goldstein, B., Cannabis in the treatment of pediatric epilepsy. O'Shaughnessy's, 7–9, 2016.